BofA Securities Downgrades Ultragenyx Pharma (RARE) to Neutral

September 3, 2026 9:40 AM

BofA Securities analyst Tazeen Ahmad downgraded Ultragenyx Pharma (NASDAQ: RARE) ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

No results found